Sage Capital Advisors llc decreased its position in shares of Abrdn Healthcare Investors (NYSE:HQH – Free Report) by 23.3% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 22,041 shares of the financial services provider’s stock after selling 6,692 shares during the quarter. Sage Capital Advisors llc’s holdings in Abrdn Healthcare Investors were worth $354,000 as of its most recent filing with the SEC.
Several other institutional investors have also modified their holdings of HQH. Penserra Capital Management LLC bought a new position in Abrdn Healthcare Investors in the 3rd quarter worth about $16,145,000. Raymond James & Associates increased its position in Abrdn Healthcare Investors by 79.8% in the 3rd quarter. Raymond James & Associates now owns 355,205 shares of the financial services provider’s stock valued at $6,614,000 after acquiring an additional 157,618 shares during the period. Needham Investment Management LLC raised its stake in Abrdn Healthcare Investors by 3.1% during the 3rd quarter. Needham Investment Management LLC now owns 255,078 shares of the financial services provider’s stock valued at $4,750,000 after acquiring an additional 7,729 shares in the last quarter. Advisors Asset Management Inc. boosted its position in Abrdn Healthcare Investors by 36.5% during the 3rd quarter. Advisors Asset Management Inc. now owns 177,820 shares of the financial services provider’s stock worth $3,311,000 after acquiring an additional 47,518 shares during the period. Finally, B. Riley Wealth Advisors Inc. boosted its position in Abrdn Healthcare Investors by 28.0% during the 2nd quarter. B. Riley Wealth Advisors Inc. now owns 90,160 shares of the financial services provider’s stock worth $1,576,000 after acquiring an additional 19,719 shares during the period. Institutional investors own 32.60% of the company’s stock.
Abrdn Healthcare Investors Price Performance
Shares of NYSE HQH traded down $0.14 during midday trading on Friday, reaching $16.58. 123,671 shares of the company traded hands, compared to its average volume of 271,497. The stock has a 50-day moving average price of $17.23 and a 200 day moving average price of $18.06. Abrdn Healthcare Investors has a 52 week low of $15.76 and a 52 week high of $19.79.
Abrdn Healthcare Investors Increases Dividend
Abrdn Healthcare Investors Profile
Abrdn Healthcare Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the healthcare sector, including the biotechnology, medical devices, and pharmaceuticals industries.
Featured Stories
- Five stocks we like better than Abrdn Healthcare Investors
- Short Selling – The Pros and Cons
- Driving Forward: Lucid’s Growing Sales and Gravity SUV’s Impact
- Investing in Construction Stocks
- Why Amazon’s Next Earnings Could Trigger a Stock Breakout
- How to Most Effectively Use the MarketBeat Earnings Screener
- With This Kind of Data, The Fed Isn’t Cutting Rates This Year
Want to see what other hedge funds are holding HQH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Abrdn Healthcare Investors (NYSE:HQH – Free Report).
Receive News & Ratings for Abrdn Healthcare Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abrdn Healthcare Investors and related companies with MarketBeat.com's FREE daily email newsletter.